Healthcare Stocks Rise as Drugmakers Face Scrutiny Under a Democratic Wave
From Market Watch — Nov 9th, 2026
Hospital stocks rallied following the Democrats' sweep of the House and Senate, as investors anticipated potential policy changes benefiting major hospital systems. Democratic lawmakers are expected to revisit Medicaid cuts and expired Affordable Care Act premium tax credits while putting proposed hospital reimbursement changes on hold. Spencer Perlman, Director of Healthcare Policy Research at Veda Partners, described incoming Senate Majority Leader Chuck Schumer as a “longtime stalwart of the hospital industry.”
However, the political shift could create challenges for health insurers and pharmaceutical companies. Democrats are expected to scrutinize Medicare Advantage payment practices, drug-pricing agreements, and policies established under the Trump administration. While major healthcare legislation may remain unlikely in the near term, renewed investigations and efforts to reverse Medicaid cuts and extend ACA subsidies could shape the industry's policy outlook.
This excerpt and any accompanying media (including audio, video, or images) are shared under the principles of fair use, for informational and archival purposes only. All rights remain with the original publisher.